8:00 a.m.
Continental Breakfast & Networking

8:30 a.m.
Opening of Day Two

8:30 a.m.

"Mobilizing" The Recruitment Funnel For Improved Results

Mobile phones have become a staple in our patients’ lives, but they are a relative rarity in research studies.  The mobile phone offers unprecedented access to engage patients, recruit them to studies and retain them throughout the entire study.  Sites, Sponsors and Subjects who have used this technology give rave reviews and have seen amazing results on their studies.

Omniscience Mobile and Parexel have teamed on multiple studies to bring modern technologies to the recruitment field.  This session will demonstrate how text messaging can significantly improve the response levels to traditional patient recruitment advertising.  Furthermore, this session will address options to deal with “study fatigue” and poor “pull through” at the site level.  This pragmatic session will help you understand:

• Why Mobile Phone technologies are essential to your research study.
• Exactly how text messaging is incorporated in patient recruitment advertising
• How to track ROI, as well as the results seen from previous studies
• How to track whether a site is actively following up on referrals generated through centralized programs
• Best practices in tracking referrals all the way through randomization and completion

Mobile technologies are fun and offer exciting ways to communicate with our patients.  Come learn how you can add this tool to your studies and see immediate benefits!  Bring your phone, as this will be an interactive session!

Jeff Lee, CEO
Omniscience Mobile

Brendan O’Neill, Director, Patient Recruiting Strategy Group
PAREXEL

9:10 a.m.

Idea Exchange: Questions, Feedback, Collaboration

9:15 a.m.

Addressing Diversity In Designing Clinical Trials To Improve Outcomes

Addressing diversity in clinical studies is a key factor to understand and improve individual patient outcomes. Barriers for enrollment of minority patients should be taken into account when planning clinical studies in order to reduce under representation of diverse racial/ethnic populations. Sponsors and investigators need to work collaboratively in developing innovative approaches to improve individual outcomes for all patients. 
You will leave this session with new ideas to help you engage a diverse population, including:

• The business drivers for inclusion of minority patients in clinical trials
• Understanding barriers to increase enrollment of minority patients in clinical trials
• Implementing activities to create a more effective approach for enrolling minority patients in clinical trials

Gerson Peltz, MD, MPH, Medical Director,
Global Pharmacovigilance & Epidemiology
Bristol-Myers Squibb

9:45 a.m.

Idea Exchange: Questions, Feedback, Collaboration

9:50 a.m.

How To Recruit Patients From “The Cloud”: Identifying The Most Appropriate Social Media Tools For Your Trial and Staying Within The Current Regulatory Guidance on Using Social Media Tools

Recent reports have shown that the Internet is currently the most popular resource for seeking health information -- even more so than consulting with medical professionals. It’s clear that the Internet is changing the way people think about their medical care. Consequently, pharma organizations can benefit from this strategic change by accessing a new, motivated pool of patients for clinical trials. However, it has been estimated that less than 5% of the ePatients know anything about clinical trials.  This is compounded by the lack of tested policies and procedures within the sponsor organizations, leaving the clinical project manager with many challenges when trying to access this valuable pool of potential trial participants.

Like other patient recruitment strategies, Internet-based advertising must be properly planned to effectively enhance patient recruitment and target motivated patients.
During this session, you’ll walk through some recent examples of social media as a platform to enhance recruitment strategies.  Examining each step – from vendor selection through program implementation – you’ll gain a greater understanding of the impact and potential roadblocks that may occur.  You’ll also learn tips for success in your own e-recruitment program, including how to:

• Identify which social media method would be most appropriate for your clinical trial
• Tap into patient advocacy blogs as well as physician and disease-specific websites
• Utilize search engine marketing – including geo-locating ad placement
• Implement tools to measure your results (i.e. Google Analytics)
• Recruit within the current regulatory guidance on using social media tools

Rodney Butt, M.Sc., MBA, Director, Project Management & Quality Systems
nutrasource

10:20 a.m.

Idea Exchange: Questions, Feedback, Collaboration

10:25 a.m.

Morning Refreshment & Networking Break

10:35 a.m.

The Science Behind Recruitment and Retention: How To Use An Evidence-Based Behavioral Model To Develop A Patient-Centric Communications Plan

In the competitive landscape of clinical research, it’s critical to have deep knowledge of the patients you are seeking to recruit.   To accomplish this, an analysis of the patient journey can serve as a foundation to drive patient engagement, ensuring successful recruitment and retention.  Insights gained from the patient journey are translated into actionable recommendations using an evidence-based behavioral model. This approach puts patients at the center of the recruitment plan, by first identifying key patient insights, and then using these insights to develop a communication plan that resonates.

During this session, you will:

• Experience how a behavioral science-based framework for communications planning can bring patients into trials more effectively
• Understand how to create lasting relationships with patients throughout the trial’s duration
• Gain a new perspective on putting the patient at the center of the recruitment plan
  

Jim Kremidas, Principal, Independent Consultant
Kremidas Consulting

Online user generated content has become one of the most trusted and engaging resources within the digital patient education ecosystem.  The WEGO Health Behavioral Intent Survey reveals the impact of community created content; tracking the path and impact of social recommendations from Consumer Opinion Leaders (aka Health Activists) to their followers.

This findings presentation and panel discussion will uncover:

• The types of content that empowers patients and changes behaviors
  
• The needs of today's most active online communities and their leaders
  
• How organizations can leverage community content to engage and recruit patients

Panelists Include:
Aaron Blocker, Crohn’s and IBD Health Activist & creator of the
Life Takes Guts organization, @LifeTakesGuts

Jordan Davidson, Endometriosis and Chronic Illness Health Activist
& Co-founder of the Endowarriors, @endowarriors

Erin Smith, Celiac Health Activist & blogger of
Gluten Free Fun, @gfreefun

Facilitator:
Bob Brooks, EVP
WEGO HEALTH

11:35 a.m.

Idea Exchange: Questions, Feedback, Collaboration

11:40 a.m.

Think Local for Global Recruitment

One size does not fit all when it comes to engaging potential study volunteers for a global clinical trial. You have to adapt your technique and material to the audience you want to engage.

The importance of understanding cultural differences is key to creating improved recruitment materials and campaigns.  Communications created with a Western bias cannot be expected to succeed in different cultures. Initiatives undertaken with insufficient knowledge of local cultures are likely to create recruitment delays. 

Words, metaphors, and images that are easily understood in North America often fail in global cultures where social and cultural attributes may differ substantially. Even something as seemingly insignificant as a model wearing a color deemed inappropriate by the local population can derail a campaign and delay a trial.

Status quo solutions for patient recruitment in clinical trials may have been all that was possible at one time, but are now increasingly deficient in terms of quality, risk, consistency and results.

The presentation focuses on cultural considerations and Transcreation - the process of creating messages that resonate across local markets. 

David Heck, Business Development Director, Life Sciences
Lionbridge Life Sciences
Conference Chairperson

12:10 p.m.
Lunch On Your Own -- But Not Alone!

Join a group of your colleagues for lunch with an informal discussion based on a patient engagement hot topic. Take this opportunity to join others in a small, interactive group setting to network and brainstorm solutions to your most pressing patient engagement, recruitment and retention concerns.

1:15 p.m.

Patient Engagement For Clinical Trials:
Common Challenges and Solutions

This follow up “round-table” exercise will explore a variety of tactics in improving patient engagement, recruitment, and retention. The challenges and questions of clinical trials are many, but this “group-think” will leverage the experience and knowledge of all attendees and participants to help identify solutions.

1:45 p.m.

Innovate Study Designs by Engaging Patients Directly for Research

The research landscape has changed. Patients are more connected than ever and eager to participate in research. However, as many as of 90% of them will never be approached to participate in a clinical study. “Dr. Google” is now the most visited “physician.”
As the landscape has changed -- including constraints such as reduced budgets, shortened timelines and increased need for more real-world data -- we must look for novel approaches to gain the data we need.

Quintiles' Digital Patient Unit (DPU) has been innovating in this space to develop solutions for our customers to prosper in this new digitally connected landscape. This session will explore case studies for several novel, direct-to-patient designs:

• Insight collection from patients to support better protocol design and study strategy
  
• Direct-to-patient studies that collect and integrate patient reported outcomes, EMR data and other data elements
  
• Virtual usage in Phase 2/3 studies
  
• Engaging with our global patient communities of 3.1 million patients in seven countries

John Reites, Director, Operations-Digital Patient Unit
Quintiles

2:15 p.m.

Idea Exchange: Questions, Feedback, Collaboration

2:20 p.m.

How To Quantify Patient Engagement Return On Investment: Cardiovascular Outcomes Study for Gout, Control vs. Test Group

This session examines a Top 10 sponsor's analysis of IVRS data comparing the attrition rates of patients who were exposed to patient engagement techniques and those who were not, from a 7,000-patient cardiovascular outcomes study of gout. Using industry-standard clinical trial costing metrics for gout trials, the presenter will also explain how to estimate the cost impact of patient attrition for both the control and test groups to help quantify patient engagement return on investment.

In this session, you will learn how to:

• Assess the impact of patient engagement techniques on reducing patient attrition in clinical trials
• Estimate the cost savings of reducing patient attrition for clinical endpoint studies

Scott H. Connor, Vice President, Marketing
Acurian, Inc.

2:50 p.m.

Idea Exchange: Questions, Feedback, Collaboration

2:55 p.m.

Interactive Panel: Hot Topics In Personalized Medicine

From NICE's rejection of Xalkori to the latest from CMS, we end 2013 with overarching issues revolving around personalized medicine that affect every therapeutic space and every player in the field--from patient, to advocate, to scientist, to clinician and every other provider, to industry and regulatory executives, and from government to private payers. Join us as an all-star panel--that is daily "in the trenches" of personalized medicine and molecular diagnostics engages the audience in an interactive session that seeks clarity amidst the clamor and confusion.  

Panel Administrator/Leader: 

Marcia K. Horn, President & CEO
(ICAN) International Cancer Advocacy Network

Panelists To Be Anounced Shortly

3:30 p.m.
Chairperson’s Recap
And Close Of General Sessions

We’ll recap the highlights of the past two days and ask you to share key insights and next steps with the group.

David Heck, Business Development Director, Life Sciences
Lionbridge
Conference Chairperson